학술논문

The rate of adverse events is comparable between simultaneous bee and vespid venom immunotherapy and bee venom mono-immunotherapy
Document Type
Journal
Source
ALLERGY; AUG 2019, 74 p235-p235, 1p. Supplement: 106
Subject
Language
English
ISSN
13989995